СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ  АНОГЕНИТАЛЬНЫХ БОРОДАВОК (ЛИТЕРАТУРНЫЙ ОБЗОР)

A.U. Khalikova; M.B. Usubaliev; A.T. Shakirova; K.S. Golyaeva; G.J. Baigashkaeva

doi:10.54890/1694-8882-2025-1-94

A.U. Khalikova M.B. Usubaliev A.T. Shakirova K.S. Golyaeva G.J. Baigashkaeva

DOI:

https://doi.org/10.54890/1694-8882-2025-1-94

Abstract

Anogenital warts are one of the most common infections affecting people of all ages and genders. This disease can lead to serious consequences, including the development of cancer. The purpose of the work is to conduct a literature review on the topic of anogenital warts. Most anogenital warts are caused by human papillomavirus types 6 and 11. Human papillomaviruses are extremely common in nature and the human population, and over time, the issues of therapy for anogenital viral warts caused by papillomaviruses become more and more relevant. In this paper, an analysis of modern scientific articles that describe various aspects of this disease was carried out. Issues such as the causes of anogenital warts, methods of diagnosis and treatment, as well as the prevention and control of the spread of this disease were considered. The results obtained allow us to conclude that anogenital warts are a serious problem for public health and require serious attention from medical science and practice. In conclusion, this work is a useful literature review that can be used as input for further research in the field of anogenital warts, as well as in the development of methods for the prevention and treatment of this disease.

Keywords:

anogenital warts, genital warts, cervical cancer, human papillomavirus, vaccination, sexually transmitted infections

Author Biographies

A.U. Khalikova, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Dermatovenereology

M.B. Usubaliev, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Dermatovenereology

A.T. Shakirova, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Dermatovenereology

K.S. Golyaeva, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Dermatovenereology

References

1. Samuel E V, Kyle J W. A systematic review of the treatment of active anogenital warts with human papillomavirus vaccines. J Am Pharm Assoc. 2024;64(1):179-185.e3. http://doi.org/10.1016/j.japh.2023.10.028

2. Camargo CC, D'Elia MPB, Miot HA. Quality of life in men diagnosed with anogenital warts. An Bras Dermatol. 2017;92(3):427-429. http://doi.org/10.1590/abd1806-4841.20175282

3. Тилеков Э.А., Ибраимова Д.Д., Болбачан О.А., Ишенова Г.И., Насирова Н.М. Первичная заболеваемость раком шейки матки по регионам Кыргызской Республики. Вестник КГМА. 2022;5:40-48. https://doi.org/10.54890/1694-6405_2022_5_40

4. Thurgar E, Barton S, Karner C, Edwards SJ. Clinical effectiveness and cost-effectiveness of interventions for the treatment of anogenital warts: systematic review and economic evaluation. Health Technol Assess. 2016 Mar; 20(24):v-vi, 1-486. http://doi.org/10.3310/hta20240

5. Komloš KF, Kocjan BJ, Košorok P, Luzar B, Meglič L, Potočnik M, et al. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens. J Med Virol. 2012;84(8):1233-41. http://doi.org/10.1002/jmv.23318

6. Bhatia N, Lynde C, Vender R, Bourcier M. Understanding Genital Warts: Epidemiology, Pathogenesis, and Burden of Disease of Human Papillomavirus. Journal of Cutaneous Medicine and Surgery. 2013;17(6 suppl):S47-S54. http://doi.org/10.2310/7750.2013.13072

7. Tyros G, Mastraftsi S, Gregoriou S, Nicolaidou E. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination. International Journal of STD & AIDS. 2021;32(1):4-13. http://doi.org/10.1177/ 0956462420958577

8. Steben M, Garland SM. Genital warts. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):1063-1073. http://doi.org/10.1016/j.bpobgyn.2014.07.002

9. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009;199:805-814. http://doi.org/ 10.1086/597071

10. Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsagué X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30. https://doi.org/10.1186/1471-2407-12-30

11. Scarbrough Lefebvre CD, Van Kriekinge G, Gonçalves MA, de Sanjose S. Appraisal of the burden of genital warts from a healthcare and individual patient perspective. Public Health. 2011;125(7):464-75. https://doi.org/10.1016/j.puhe.2011.01.016

12. Rosen T. Condylomata acuminata (anogenital warts) in adults: Epidemiology, pathogenesis, clinical features, and diagnosis. Dermatol online J. 2021;19:18559

13. Lynde C, Vender R, Bourcier M, Bhatia N. Clinical features of external genital warts. J Cutan Med Surg. 2013;17 Suppl 2:S55-S60.

14. Gilson R, Nugent D, Werner RN, Ballesteros J, Ross J. IUSTI-Europe guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol. 2020;34(8):1644-1653. https://doi.org/10.1111/jdv.16522

15. Kreuter A, Siorokos C, Oellig F, Silling S, Pfister H, Wieland U. High-grade Dysplasia in Anogenital Warts of HIV-Positive Men. JAMA Dermatol. 2016;152(11):1225-1230. https://doi.org/10.1001/jamadermatol.2016.2503

16. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol. 2004;193(1):35-44. https://doi.org/10.1007/s00430-003-0181-2

17. Олина А.А., Ширинкина Е.В., Метелева Т.А., Шевлюкова Т.П. Остроконечные кондиломы. Официальная статистика, клинические проявления и эффективность терапии. Медицинский совет. 2019;(13):86-92. https://doi.org/ 10.21518/2079-701X-2019-13-86-92

18. Российской общество дерматовенерологов и косметологов. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд. М.: Деловой экспресс; 2016. 768 с.

19. Назарова Н.М., Некрасова М.Е., Прилепская В.Н., Гусаков К.И., Трофимов Д.Ю. Аногенитальные кондиломы, ассоциированные с ВПЧ. Медицинский совет. 2018;(13):10-15.

20. Handsfield HH. Clinical presentation and natural course of anogenital warts. Am J Med. 1997;102(5A):16-20. https://doi.org/10.1016/s0002-9343(97)00179-4

21. Ockenfels HM. Therapeutic management of cutaneous and genital warts. J Dtsch Dermatol Ges. 2016;14:892–899. https://doi.org/10.1111/ddg.12838

22. Yuan J, Ni G, Wang T, Mounsey K, Cavezza S, Pan Xб et al. Genital warts treatment: Beyond imiquimod. Hum Vaccin Immunother. 2018;14(7):1815-1819. https://doi.org/10.1080/21645515.2018.1445947

23. Bertolotti A, Ferdynus C, Milpied B, Dupin N, Huiart L, Derancourt C. Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials. Dermatol Ther (Heidelb). 2020;10(2):249-262. https://doi.org/10.1007/s13555-020-00357-z

24. Werner RN, Westfechtel L, Dressler C, Nast A. Self-administered interventions for anogenital warts in immunocompetent patients: a systematic review and meta-analysis. Sex Transm Infect 2017; 93:155-161. https://doi.org/10.1136/sextrans-2016-052768

25. Rosen T, Nelson A, Ault K. Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men. Cutis. 2015;96:277–282.

26. Berman B, Wolf J. The role of imiquimod 3.75% cream in the treatment of external genital warts. Skin Therapy Lett. 2012;17(4):5–7.

27. O'Mahony C, Gomberg M, Skerlev M, Alraddadi A, de Las Heras-Alonso ME, Majewski S, et al. Position statement for the diagnosis and management of anogenital warts. J Eur Acad Dermatol Venereol. 2019;33(6):1006-1019. https://doi.org/10.1111/jdv.15570

28. Schöfer H, Tatti S, Lynde CW, Skerlev M, Hercogová J, Rotaru M et al. Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults. Int J STD AIDS. 2017;28(14):1433-1443. https://doi.org/10.1177/0956462417711622

29. Gross GE, Werner RN, Becker JC, Brockmeyer NH, Esser S, Hampl M, et al. A. S2k guideline: HPV-associated lesions of the external genital region and the anus – anogenital warts and precancerous lesions of the vulva, the penis, and the peri- and intra-anal skin (short version). J Dtsch Dermatol Ges. 2018;16(2):242-255. https://doi.org/10.1111/ddg.13441

30. Bouscarat F, Pelletier F, Foue´re´ S, Janier M, Bertolloti A, Aubin F. Verrues génitales (condylomes) externs [External genital warts (condylomata)]. Ann Dermatol Venereol. 2016;143(11):741–5. French. https://doi.org/10.1016/j.annder. 2016.09.013

31. Yakely AE, Avni-Singer L, Oliveira CR, Niccolai LM. Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States. Sex Transm Dis. 2019;46(4):213-220. https://doi.org/10.1097/OLQ.0000000000000948

32. Умаралиева Ж.С. Перекрестный иммунитет к онкогенным типам (45 и 31) у женщин с ВПЧ – индуцированной неоплазией шейки матки на фоне специфической терапии. Вестник КРСУ. 2013;13(1):131-135.